Importantly, CCR1 knockdown reversed the tumor-promoting effects of CCL15, providing strong evidence that CCL15 exerts its oncogenic role in ESCC primarily through CCR1 activation. The gene discussed is CCR1; the disease is esophageal squamous cell carcinoma.